financetom
Technology
financetom
/
Technology
/
Assessing Verint Systems: Insights From 4 Financial Analysts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Assessing Verint Systems: Insights From 4 Financial Analysts
Jul 18, 2025 11:38 AM

In the latest quarter, 4 analysts provided ratings for Verint Systems ( VRNT ) , showcasing a mix of bullish and bearish perspectives.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 1 0 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 1 1 0 0 0
3M Ago 1 0 0 0 0

Insights from analysts' 12-month price targets are revealed, presenting an average target of $32.5, a high estimate of $40.00, and a low estimate of $30.00. Marking an increase of 8.33%, the current average surpasses the previous average price target of $30.00.

Deciphering Analyst Ratings: An In-Depth Analysis

The analysis of recent analyst actions sheds light on the perception of Verint Systems ( VRNT ) by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Catharine Trebnick Rosenblatt Announces Buy $40.00 -
Daniel Ives Wedbush Maintains Outperform $30.00 $30.00
Joshua Reilly Needham Maintains Buy $30.00 $30.00
Joshua Reilly Needham Maintains Buy $30.00 $30.00

Key Insights:

Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Verint Systems ( VRNT ). This insight gives a snapshot of analysts' perspectives on the current state of the company.

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Verint Systems ( VRNT ) compared to the broader market.

Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

Capture valuable insights into Verint Systems's ( VRNT ) market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Verint Systems ( VRNT ) analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Verint Systems

Verint Systems Inc ( VRNT ) with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint ( VRNT ) comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.

Unraveling the Financial Story of Verint Systems

Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Challenges: Verint Systems's ( VRNT ) revenue growth over 3M faced difficulties. As of 30 April, 2025, the company experienced a decline of approximately -5.96%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.14%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Verint Systems's ( VRNT ) ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.27% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Verint Systems's ( VRNT ) financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.1%, the company showcases efficient use of assets and strong financial health.

Debt Management: Verint Systems's ( VRNT ) debt-to-equity ratio is below the industry average. With a ratio of 0.49, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Understanding the Relevance of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The USDCHF price reinforces its intraday gains- Analysis-21-10-2025
The USDCHF price reinforces its intraday gains- Analysis-21-10-2025
Oct 20, 2025
The (USDCHF) price rose in its last intraday trading, due to the stability of the key support at 0.7910, which provide renewed bullish momentum that is reinforced by the emergence of the positive signals on the relative strength indicators, after offloading its overbought conditions, opening the way for achieving more of the gains on the near-term basis, on the other...
GigaDevice Deepens Commitment to Japan, Advancing Local Services and Global Collaboration
GigaDevice Deepens Commitment to Japan, Advancing Local Services and Global Collaboration
Oct 20, 2025
TOKYO--(BUSINESS WIRE)-- GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, has officially opened its new office in Minato City, Tokyo. This milestone reflects the company’s deepening commitment to the Japanese market and marks a significant step in enhancing local customer support, strengthening regional collaboration, and advancing its global development efforts. This press...
Brent crude oil witnesses fluctuated trading- Analysis-21-10-2025
Brent crude oil witnesses fluctuated trading- Analysis-21-10-2025
Oct 20, 2025
The (Brent) price fluctuated on its last intraday levels, taking advantage of the emergence of the positive signals on the relative strength indicators, which provides some bullish momentum to face the dominance of the main bearish trend on the short-term basis, amid its trading alongside supportive trend line for this track, besides the continued negative pressure due to its trading...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
Oct 20, 2025
TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind reported that its latest AI model successfully generated and experimentally validated a new hypothesis for cancer treatment, calling it a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved